Merck to Hold Investor Briefing at Boston Research Facility

By Business Wire,  April 28, 2014, 07:30:00 AM EDT

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold an Investor Briefing on Tuesday, May 6, 2014 starting at 9:00 a.m. EDT at its research facility in Boston, MA. During the event, members of Merck's senior management will detail the company's research strategy, showcase candidates from the research and development pipeline and provide a business update.

There will be a live webcast of the event available on Merck's website at Software needed to listen to the webcast may be obtained on the corporate website and should be downloaded prior to the beginning of the webcast. A replay of the webcast will be available by the end of the day on May 6.

About Merck

Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit and connect with us on Twitter, Facebook and YouTube.

Source: Merck

This article appears in: News Headlines

Referenced Stocks: MRK

Latest News Video

Actress Fran Drescher LIVE
Actress Fran Drescher LIVE          

Most Active by Volume

Company Last Sale Change Net / %
FB $ 75.363 0.38 ▲ 0.51%
AAPL $ 97.3735 0.34 ▲ 0.35%
AMD $ 3.76 0.03 ▲ 0.80%
SIRI $ 3.44 0.01 ▼ 0.29%
GM $ 35.02 0.72 ▼ 2.01%
P $ 24.825 3.90 ▼ 13.56%
BAC $ 15.575 0.05 ▼ 0.29%
RFMD $ 10.9253 0.40 ▲ 3.75%

As of 7/25/2014, 12:28 PM